Clinical Trials Browser

Approved for marketing × Carcinoma, Hepatocellular × Clear all

NCT00906984 2024-01-08

TheraSphere

Approved for marketing

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02436044 2019-08-20

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Approved for marketing

Gastrointestinal

Carcinoma, Hepatocellular, Wounds and Injuries